Recently, The International Federation of Sports Medicine (FIMS) signed a formal collaboration agreement with Translational Exercise Biomedicine (TEB) , announcing TEB as its official partnership journal (2025-2030), the first of its kind in Asia .
Established in 1928, FIMS is home to four Continental Sports Medicine Associations and 117 National Sports Medicine Associations worldwide, uniting 125.000 sports physicians from 117 countries. Recognized by the IOC, the IPC and an Associate Member of SportAccord, FIMS actively networks and links with all relevant international sports and political organizations. Prof essor Fabio Pigozzi, President of FIMS , recognized ‘TEB as a good partner regarding disseminating academic research in the field of translational sports medicine worldwide’.
TEB is an international scholarly journal, co-hosted by Shanghai Jiao Tong University & Guangzhou Sport University and published by De Gruyter Brill in 2024, an international publishing giant, focuses on exercise interventions and human health improvements through translational research. As Executive Editor-in-Chief of TEB, Prof essor Cheng Suling from Shanghai Jiao Tong University and Emerita Professor of University of Jyväskylä in Finland believed that ‘bilateral sides will join hands to enhance research publication, host co-branded events, strengthen education and knowledge exchange and advance global advocacy for sports medicine around the globe!’ Professor Hou Xiaohui, Vice President of Guangzhou Sport University highlighted‘the milestone collaboration between TEB and FIMS will significantly accelerate the development of translational sport medicine in China’.
Translational Exercise Biomedicine
News article